William Geist compensation by year
BIO-TECHNE Summary Compensation Table · all 4 fiscal years held| Component | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Salary | $239,600 | $530,000 | $551,200 | $573,200 |
| Bonus | $0 | $0 | $0 | $0 |
| Stock awards | $1,224,789 | $449,915 | $1,519,768 | $1,206,585 |
| Option awards | $674,897 | $1,350,043 | $1,417,508 | $593,448 |
| Non-equity incentive | $425,000 | $0 | $144,855 | $748,026 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $0 | $3,669 | $13,887 | $18,040 |
| Total | $2,564,286 | $2,333,628 | $3,647,219 | $3,139,299 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIO-TECHNE Corp DEF 14A filed September 19, 2025, accession 0001308179-25-000599, and prior-year filings. Open the filing on EDGAR.
How this page was built: the BIO-TECHNE Corp filed document, accession 0001308179-25-000599. Every figure is read from that document and cited to the page and table it appears in. Filed September 19, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 19,823 | $1,420,318 | — |
| PSU | 8,377 | $600,212 | — |
| PSU | 7,140 | $511,581 | — |
| PSU | 3,360 | $240,744 | — |
| RSU | 3,320 | $237,878 | — |
| Option | 30,059 | — | $84.61 |
| Option | 22,200 | — | $94.52 |
| Option | 7,956 | — | $100.39 |
Per the Outstanding Equity Awards at Fiscal Year-End table in BIO-TECHNE Corp's FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
19 Form 4 lines since the FY2025 proxy (filed September 19, 2025)current to 2026-11-07 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-17 | Grant or award derivative | — | 23,985 | $0.00 | 23,985 |
| 2026-08-17 | Grant or award derivative | — | 14,762 | $0.00 | 14,762 |
| 2026-08-15 | Tax withholding | — | 1,976 | $72.40 | 24,943 |
| 2026-08-15 | Exercise or conversion | — | 6,416 | $0.00 | 26,919 |
| 2026-08-15 | Disposition to the issuer derivative | — | 22,898 | $0.00 | 1,526 |
| 2026-08-15 | Disposition to the issuer derivative | — | 8,507 | $0.00 | 0 |
| 2026-08-15 | Exercise or conversion derivative | — | 567 | $0.00 | 8,507 |
| 2026-08-15 | Disposition to the issuer derivative | — | 698 | $0.00 | 8,376 |
The 8 most recent of 19 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
BIO-TECHNE’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Kim Kelderman | President and CEO | $8,151,181 |
| James Hippel | Executive Vice President and CFO | $7,027,382 |
| William Geist · this page | President, Protein Sciences | $3,139,299 |
| Matthew McManus | President, Diagnostics and Spatial Biology | $2,846,619 |
| Shane Bohnen | Senior Vice President and General Counsel | $1,980,732 |
The full BIO-TECHNE compensation record
free company briefThis page is one person within BIO-TECHNE's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the BIO-TECHNE proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order BIO-TECHNE's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BIO-TECHNE's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order TECH
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.